Table 4.
Biomarker | Bayview (“without” mask) vs College site Ratio (95% CI) |
---|---|
A2M | 0.887 (0.755, 1.043)+a |
Adiponectin | 1.184 (1.013, 1.385)*b |
AGP | 0.749 (0.590, 0.952)*a |
CRP | 1.410 (0.887, 2.240)+a |
Haptoglobin | 0.852 (0.734, 0.989)*a |
IL-1β | 1.050 (0.999, 1.104)+b |
IL-4 | 1.317 (1.021, 1.699)*a |
IL-6 | 1.143 (1.002, 1.305)*c |
PF4 | 0.847 (0.709, 1.011)+a |
Plasma ET-1(1–21) | 1.497 (0.957, 2.340)+a |
Plasma ET-3 | 1.330 (1.037, 1.705)*a |
Saliva BET-1 | 1.302 (1.034, 1.641)*c |
Saliva ET-1(1–21) | 1.167 (1.031, 1.320)*b |
Saliva ET-3 | 1.114 (0.979, 1.267)+b |
TNF-α | 1.076 (1.005, 1.151)*c |
vWF | 0.552 (0.349, 0.875)*a |
*p < 0.05; +p < 0.1(not significant, trend only)
aCovariates: Treatment period, carry over, age, sex, BMI, atmospheric pressure, temperature, relative humidity
bCovariates: Treatment period, carry over
cCovariates: Treatment period, carry over, age, sex, BMI